Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Non-Current Debt (2021 - 2025)

Bioregenx's Non-Current Debt history spans 5 years, with the latest figure at $181825.0 for Q4 2025.

  • Quarterly results put Non-Current Debt at $181825.0 for Q4 2025, down 28.59% from a year ago — trailing twelve months through Dec 2025 was $181825.0 (down 28.59% YoY), and the annual figure for FY2025 was $181825.0, down 28.59%.
  • Non-Current Debt for Q4 2025 was $181825.0 at Bioregenx, down from $1.2 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.2 million in Q3 2025 to a low of $150000.0 in Q1 2024.
  • The 5-year median for Non-Current Debt is $254606.0 (2024), against an average of $522705.8.
  • The sharpest move saw Non-Current Debt plummeted 51.57% in 2024, then soared 659.16% in 2025.
  • Year by year, Non-Current Debt stood at $197837.0 in 2021, then dropped by 1.02% to $195811.0 in 2022, then skyrocketed by 168.46% to $525681.0 in 2023, then crashed by 51.57% to $254606.0 in 2024, then decreased by 28.59% to $181825.0 in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $181825.0, $1.2 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.